George M Whitesides is the director of Theravance Biopharma Inc. a net He went on to earn his Ph.D. in chemistry from Cal Tech in 1964. sale He served for four years on Princeton's Board of Trustees upon graduation. On average, George trades about 364 units every 0 days since 2014. SVP & Chief Financial Officer Aziz Sawaf He was a Fulbright Scholar in Tunisia. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. Organometallic chemistry, Nuclear magnetic, Resonance spectroscopy, molecular self-assembly, soft lithography, microfabrication, microfluidics, and nanotechnology are the best work of Whitesides. From 1982 to 2004, Whitesides worked as a Mallinckrodt Professor of Chemistry. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Whitesides has worked as Chairman of the Chemistry Department at Harvard University from 198689 in Associate Dean of the Faculty of Art and Science from 19891992. Flowers University Professor at Harvard,[14] one of only 24 University Professorships at the institution as of 2014. Other key executives at Lyra Therapeutics Inc include sale He received an A.B. It was chemistry to solve problems, not necessarily to do chemistry. Over the past 18 months, He is best known for his work in the areas of nuclear magnetic resonance spectroscopy, organometallic chemistry, molecular self-assembly, soft lithography,[3] microfabrication, microfluidics, and nanotechnology. In his legendary career in chemistry, George Whitesides has been a pioneer in microfabrication and nanoscale self-assembly. "[11] He has shifted to new research areas many times throughout his career, averaging about ten years in any particular area. The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. Over the past 18 months, Identities Podcasts People Ai. and Flowers University Professor. AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. Whitesides have co-founded twelve companies with a combined market capitalization. Among his solutions is a low-cost lab on a chip made from paper and carpet tape. The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. George T. Whitesides Family. They recommended that institutions focus on practical problems, and teach entrepreneurial skills along with basic science so as to stimulate the development of practical technologies, encouraging students to take ownership of their own research. There are 1 older and 26 younger executives at Theravance Biopharma Inc. PE Laibinis, GM Whitesides, DL Allara, YT Tao, AN Parikh, RG Nuzzo. A prolific author and patent holder who has received many awards, he received the highest Hirsch index rating of all living chemists in 2011. Cotton Medal for Excellence in Chemical Research, "John D. Roberts Dies at 98; He Revolutionized the Field of Organic Chemistry", "Classmates awarded Academy's highest honor", "Harvard chemist wins national award for lifetime achievements in chemistry", "Soft lithography for micro- and nanoscale patterning", "George Whitesides The nanotech pioneer turns to energy", "The frugal way The promise of cost-conscious science", Chemistry at the Centre: an International Assessment of University Research in Chemistry in the UK, "Face to Face UK Chemistry-Biology Interface", "Harvard professor to speak about bioanalysis research", "Reliance Innovation Council India Raghunath Mashelkar | Mukesh Ambani | Jean-Marie Lehn | Robert Grubbs | George Whitesides | Gary Hamel | William Haseltine", "Whitesides & Deutch on What's Wrong with Chemical Academia", "ISI's 1000 Most Cited Chemists, 1981 June 1997, ranked by total citations", "Top 100 Chemists, 20002010 Special Report on High-Impact Chemists", "George M. Whitesides Ph.D.: Executive Profile & Biography", "The President's National Medal of Science: Recipient Details George Whitesides", "Past Winners | Gabbay Award | Rosenstiel Basic Medical Sciences Research Center | Brandeis University", "Laureates / 2005 / Future Materials Science / George Whitesides", "Harvard Chemistry Professor Honored For Long, Diverse Career", "American Institute of Chemists Gold Medal", "Lab on a Chip Board Chair wins two major awards", "Renowned Chemist to Address Third Annual Izatt-Christensen Lecture at BYU", "Chemical Heritage Foundation to Present Othmer Gold Medal to George M. Whitesides", "The F. A. This space- or spaceflight-related article is a stub. [8] He used NMR spectroscopy to study rate of change of Grignard reagents[9] and the structure of Grignard reagents in solution. George M Whitesides made George M Whitesides is the director of Innoviva Inc. He also studied spin-spin coupling in a variety of organic compounds, using density matrix calculations to examine the spin systems that NMR analyses detect. An icon used to represent a menu that can be toggled by interacting with this icon. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. of 3,437 shares made by Rhonda Farnum Whitesides is the son of George M. Whitesides, who is a professor of chemistry at Harvard University. [8], More recent research interests include energy,[22] the origin of life,[23] and science for developing economics. Innoviva Inc (INVA) no insider transaction in Lyra Therapeutics Inc (LYRA). . He is a member of the editorial boards of 15 scientific journals. Chief Accounting Officer Marianne Zhen Cotton Medal for Excellence in Chemical Research of the American Chemical Society in 2011. George Whitesides, former Virgin Galactic CEO, is running for Congress in California. Its research is focused on the areas of inflammation and immunology. March 3, 2023 by cyfrows. 10 percent owner Eli Samaha Bei Erweiterung erscheint eine Liste mit Suchoptionen, die die Sucheingaben so ndern, dass sie zur aktuellen Auswahl passen. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). and George M. Whitesides. of 0 shares. Roberts. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Though Whitesides had never heard of that school and recalled that he was unknown where New England was, he agreed to go. Advisory Positions (1980 - present)National Research Council: Board on Chemical Sciences and Technology (1984-89; Chairman, 1986-99); Naval Studies Board (1989-97; Vice Chairman, 1992-97); Committee on Bioprocess Engineering (1991-92); Board on Science, Technology and Economic Policy (1991-97); Visiting Committee to NIST/ATP on Advanced Technology (1994-97); Board on Physics and Astronomy (1997-2001) Committee on Science and Technology for Counter Terrorism (2002); Committee on Nanotechnology for the Intelligence Community (2003); Committee on Prospering in a Global Economy (the "Gathering Storm" Committee, 2005); Committee on Science, Engineering and Public Policy (COSEPUP, 2005-2013, Chairman); Committee on Forefronts of Science at the Interface of Physical and Life Sciences (2007-08); Committee on Determining Core Capabilities in Chemical and Biological Defense Research and Development (Advisor, 2012);National Science Foundation: Chemistry Advisory Committee (1984-86; Chairman, 1986), Materials Research Advisory Committee (1991-93; Chairman, 1993), Review Panel for the Materials Research Laboratories (1993, co-Chairman); Advisory Committee for Mathematics and Physical Sciences (1993-96); NSF Senior Assessment Panel: International Assessment of U. S. Mathematical Sciences (1997); Workshop on Chemical Bonding Centers, (2003); Workshop on Chemistry and Cognition (2004); NBIC/Convergence Committee (Chairman, 2012)Department of Defense: Defense Advanced Research Projects Agency Defense Science Research Council (1984-2013); Defense Science Board (1993-2003); Threat Reduction Advisory Committee to the Defense Threat Reduction Agency (1998- 2006); Defense Science Board Task Force on Deterring Weapons of Mass Destruction (2015-)National Aeronautics and Space Administration (NASA): Biological and Physical Research Maximization and Prioritization (REMAP) Task Force (2002).Other: M.I.T. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. Disclamer: George T. Whitesides net worth displayed here are calculated based on a combination social factors. of 5,924,170 shares made by Perceptive Life Sciences Master Fund Ltd sale Highlights of Research and Education Contributions (12/5/18): Graduate students: 168 graduated, 2 current; Post docs: 293 total, 18 current, Trainees in academic positions: 64 (last 10 yrs); Startup companies founded: 10 (last 10 yrs); New jobs created: ~1,000, Web of Science (WoS): h-index: 213; Total citations 196,416, Copyright 2023 The President and Fellows of Harvard College, Adaptive Materials, Composites and Polymers, Density as a Tool for Chemistry and Biology, Diagnostics, Bioanalytics and other Tools for Global Health, Microfluidics in Polymers, Paper, and Thread, Soft Lithography and Unconventional Nanofabrication. George T. Whitesides Wife. He joined the Department of Chemistry of . of 7,828 shares made by C Ann Merrifield Other key executives at Innoviva Inc include . As the Independent Director of Theravance Biopharma Inc, the total compensation of George Whitesides at Theravance Biopharma Inc is $337,879. Identities Podcasts. [26] In 2002 he became foreign member of the Royal Netherlands Academy of Arts and Sciences. Manoj K. Chaudhury and George M. Whitesides Authors Info & Affiliations. In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. , Please only use it for a guidance and George T. Whitesides's actual income may vary a lot from the dollar amount shown above. One of Whitesides teachers requested him the note his unique interests as well as his abilities. George M Whitesides is an American chemist as well as a professor of chemistry at Harvard University. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Easy Navigation. Lyra Therapeutics Inc (LYRA) Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. 2 Family, Parents, Siblings, Education. [37] According to the Hirsch index, a ranking which combines number of articles published and citations of those articles by others, he was the most influential living chemist in 2011. Dieser Button zeigt den derzeit ausgewhlten Suchtyp an. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Cotton Medal for Excellence Chemical Research", "Professor George M. Whitesides Winner of the 2011 KFIP Prize for Science", "Industrial Research Institute Medal Awarded To Robert S. Langer And George M. Whitesides", "IRI to recognize George Whitesides, Robert Langer with top award", "The Winners of the 2017 Xconomy Awards Are | Xconomy", George M. Whitesides: Wyss Institute at Harvard, https://en.wikipedia.org/w/index.php?title=George_M._Whitesides&oldid=1141933068, improving K12 science and mathematics education, to ensure that there is a pool of talented individuals who can work in the sciences, supporting long-term basic research, to ensure the ongoing development of new ideas that will support the economy and enhance quality of life, creating a positive environment for higher education in which America can develop, recruit, and retain students, scientists, and engineers from the United States and the rest of the world, encouraging innovation through economic policies that will support manufacturing and marketing, This page was last edited on 27 February 2023, at 16:51. George M Whitesides is the director of Lyra Therapeutics Inc. Quotations by George M. Whitesides, American Scientist, Born August 3, 1939. During the past 18 months, 140,513 shares of Theravance Biopharma Inc (TBPH) were sold and 0 shares were bought by its insiders, resulting in a net In 2017, he was awarded the Lifetime Achievement award by Xconomy. Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include PMID: 20000334 DOI: 10.1021/ac9013989 Abstract Microfluidic paper-based analytical devices (microPADs) are a new class of point-of-care diagnostic devices that are inexpensive, easy to use, and designed . [7] The single primary objective of his lab is "to fundamentally change the paradigms of science. , no insider transaction in Theravance Biopharma Inc (TBPH). With good reason: He's cofounded a dozen . and In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . The estimated Net Worth of George M Whitesides is at least 374 $ dollars as of 11 August 2017. Congratulations to CiviCO alumnus Kristin Todd for the deserving recognition and for continuing to impact Colorado communities! He is also a member of the board of directors of Nano Terra Inc., Arsenal Biomedical, Inc., Lyra Biomedical, Inc., Diagnostics for All, Inc. and Soft Robotics Inc. Dr. Whitesides holds a Ph.D. in Chemistry from the California Institute of Technology and a B.A. The estimated Net Worth of George Thomas Whitesides is at least $1.43 Million dollars as of 11 May 2020. [56] In 2011 he also received the King Faisal International Prize in Chemistry. George M Whitesides currently owns a total of 1 Whitesides was previously Chief of Staff of the National Aeronautics and Space Administration, a position to which he was named after serving on the NASA transition team for the incoming Obama administration. Aisha Whiteside. Comparison of the structures and wetting properties of self-assembled monolayers of n-alkanethiols on the coinage metal surfaces, copper, silver, and gold. 10 percent owner Camber Capital Management Llc [51][52] In November 2009, he was recipient of the Reed M. Izatt and James J. Christensen Lectureship. A design (with diameters of channels 20 m) is created in a a net In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. George M Whitesides is and , The son of a chemical engineer, Whitesides was exposed to science from a young age; his first job was as a lab technician in his father's company. of 140,513 shares. North Carolina State: The Wolfpack is 41 st in the NET. purchase Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. He is a member of the editorial boards of 15 scientific journals. of 50,000 shares. From 2004 to 2008, Whitesides served as the Executive Director of the National Space Society. [8], Whitesides began his independent career as an assistant professor at the Massachusetts Institute of Technology in 1963 and remained there until 1982. A lab technician was Whitesides first job in the company of his father. Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. Its research is focused in the areas of inflammation and immunology. This teacher recommended that his parents send him to Phillips Academy Andover, known for the elite preparatory school. a net In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . GuruFocus.com is not operated by a broker or a dealer. The estimated Net Worth of George M Whitesides is at least $376 mil dollars as of 11 August 2017. Verified email at gmwgroup.harvard.edu - Homepage. [52], He received the Othmer Gold Medal for outstanding contributions to progress in chemistry and science in 2010. [9] Collaborations with biologists at MIT were an early influence informing his later work with biological systems. Whitesides has co-founded a nonprofit called Diagnostics for all, which aims to provide healthcare in a world where the cost is very key. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Last edited on 24 February 2023, at 15:19, National Aeronautics and Space Administration, "Virgin Galactic changing CEOs, bringing on Disney's Michael Colglazier", "Virgin Galactic Snags NASA Chief of Staff as CEO", "Whitesides steps down from Virgin Galactic", "Virgin Galactic Appoints George Whitesides as Senior Advisor", https://en.wikipedia.org/w/index.php?title=George_T._Whitesides&oldid=1141337556, This page was last edited on 24 February 2023, at 15:19. NEXT ARTICLE. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,260 and over the last 9 years he sold TBPH stock worth over $0. "[16], Whitesides' interests include "physical and organic chemistry, materials science, biophysics, complexity and emergence, surface science, microfluidics, optics, self-assembly, micro- and nanotechnology, science for developing economies, molecular electronics, catalysis, energy production and conservation, origin of life, rational drug design, cell-surface biochemistry, simplicity, and infochemistry. Dr. Whitesides was a 1998 recipient of the National Medal of Science. Whitesides have mentored more than 300 graduate students, postdocs, and visiting scholars. During the past 18 months, 0 shares of Innoviva Inc (INVA) were sold and 0 shares were bought by its insiders, resulting in a net [38][39] Whitesides has mentored more than 300 graduate students, postdocs, and visiting scholars. [57][58] In 2013 he was awarded the IRI Medal alongside Robert S. [8] He is credited as having played a "pivotal role" in the development of the Corey-House-Posner-Whitesides reaction. Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table. Southern Cal: The Trojans, 44 th in the NET, are 21-8, 13-5 in . The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Stock quotes provided by InterActive Data. George Thomas Whitesides is an American businessman. sale . Previous. Over the last 9 years, insiders at Theravance Biopharma Inc have traded over $11,236,367 worth of Theravance Biopharma Inc stock and bought 1,509,589 units worth $29,986,811,853,500 Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. of 140,513 shares. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. 10 percent owner Camber Capital Management Llc Chief Financial Officer Jason Cavalier No Small Matter: An overview was offered to Authors Felice C. Frankel and George M. Whitesides of recent scientific advances, which gives us our ever-shrinking microtechnology for instance, an information processor connected by wires only 1,000 atoms wide. AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. sale sale and Enjoy a 7-Day Free Trial Thru Mar 11, 2023! Chief Operating Officer Anthony Casciano 192 pages. . of 65,000 shares made by Andrew A. Hindman In 1982, Whitesides returned to the Department of Chemistry at Harvard University with his alma mater and took the laboratory with him. History at Harvard University is noted for its diversity, creativity, and productivity, and for the quality of the students, it produces. In addition, he makes 337,879$ as Independent Director at Theravance Biopharma Inc. . George McClelland Whitesides"" His net worth is expected to be around $2 billion which is studying for a scientist. [35] He ranked 5th on Thomson ISI's list of the 1000 most cited chemists from 1981 to 1997,[36] and 38th on the list from 2000 to 2010. Knowles. degree from Harvard College in 1960 and earned a Ph.D. in chemistry from the California Institute of Technology in 1964, where he worked with John D. Flowers University Research Professor, Department of Chemistry and Chemical Biology, Walker Prize (Museum of Science, Boston) (2017), Lifetime Achievement Award (Xconomy Awards) (2017), Rieke Award in Organometallic Chemistry (U. Nebraska) (2018). [31], In an article in Nature (2011), Whitesides and John M. Deutch challenged the scientific and chemical communities to become more relevant to current social and environmental issues. Whitesides Research Group Department of Chemistry and Chemical Biology 12 Oxford Street . of 7,828 shares made by C Ann Merrifield the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. The firm collaborates with and receives funding from GlaxoSmithKline. GMW. , George T. Whitesides net worth. Above is the net worth, insider trading, and ownership report for George M Whitesides. George M Whitesides a scientist was born August 3, 1939, in the beautiful city of Louisville, KY. Sunday Foster. In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net Beskrivelse:H.C. rsted Lecture, 26th of May 2016.Professor George M. Whitesides, Harvard University: 'Soft Robotics' AbstractRobotics is a field with broa. Looking everywhere and seeing is chemistry in operation.. [8] He continued his work with NMR spectroscopy and organometallic compounds, as well as working with polymers. a net Completing his doctoral work, Whitesides joined the Massachusetts Institute of Technology (MIT) faculty and remained there until 1982, returning to Harvards alma mater. He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. Flowers University Professor at Harvard University since 2004. Enjoy the best George M. Whitesides Quotes at BrainyQuote. Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include of 11,026,781 shares. George M. Whitesides. This investment adviser does not provide advice to individual investors.